Jung Wonyoung, Cho In Young, Jeon Keun Hye, Yeo Yohwan, Cho Jongho, Jung Kyu-Won, Choi Kui Son, Shin Dong Wook, Lee Jungkwon
Department of Family Medicine / Obesity and Metabolic Health Center, Kangdong Sacred Heart Hospital, Seoul, Republic of Korea; Department of Medicine, School of Medicine, Sungkyunkwan University, Seoul, Republic of Korea.
Department of Family Medicine/Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lung Cancer. 2024 Dec;198:108031. doi: 10.1016/j.lungcan.2024.108031. Epub 2024 Nov 23.
Low-dose computed tomography screening reduces lung cancer and overall mortality, but the participation rate remains low. The objective of this study was to develop a decision aid (DA) that addresses the overabundance of healthcare options and barriers to participation in lung cancer screening (LCS) among the general population aged 40-79 years in Korea.
The DA was developed by following the International Patient Decision Aid Standards process. To evaluate the DA, participants aged 40-79 years were purposively sampled from four districts of the Seoul metropolitan area, with 25 individuals from each decade of the age range. Participants used the DA for LCS, and pre-post comparison was conducted. The primary outcome was a change in intention to undergo LCS after completing the DA. The secondary outcomes were changes in knowledge and attitude about LCS, decisional conflict, and the perceived usefulness of the DA.
The DA prototype contained lung cancer risk assessment and decision-making components that addressed knowledge, risks, benefits, costs, and personal values. In a pilot study of 100 participants (mean age 59.0 [SD 11.1] years, 80 % male, 25 % of whom had undergone LCS), knowledge about LCS increased (mean [SD] score [out of 100] before vs. after: 68.3 [13.4] vs. 73.6 [18.0], p < 0.001). A positive change in attitude was observed (p = 0.004), but the intention to screen remained consistent (70 % before vs. 72 % after; p = 0.650). Eighty-eight participants reported the lowest level of conflict in decision-making, and most reported that the DA was useful (mean [SD] score 78.8 [9.0] out of 100). 72 % reported that the DA facilitated self-decision-making, but 27 % felt the DA recommended LCS.
This study highlights the potential of a well-designed DA to enhance knowledge and attitudes about LCS, but those improvements did not translate to a significant change in screening intentions.
低剂量计算机断层扫描筛查可降低肺癌发病率和总体死亡率,但参与率仍然较低。本研究的目的是开发一种决策辅助工具(DA),以解决韩国40 - 79岁普通人群中医疗保健选择过多以及参与肺癌筛查(LCS)存在的障碍问题。
该DA是按照国际患者决策辅助标准流程开发的。为评估该DA,从首尔大都市区的四个区有目的地抽取了40 - 79岁的参与者,每个年龄段十年抽取25人。参与者使用该DA进行LCS,并进行前后比较。主要结果是完成DA后进行LCS的意愿变化。次要结果是关于LCS的知识和态度变化、决策冲突以及对DA的感知有用性。
DA原型包含肺癌风险评估和决策制定组件,涉及知识、风险、益处、成本和个人价值观。在一项对100名参与者的试点研究中(平均年龄59.0[标准差11.1]岁,80%为男性,其中25%已接受LCS),关于LCS的知识有所增加(平均[标准差]得分[满分100分]前后比较:68.3[13.4]对73.6[18.0],p<0.001)。观察到态度有积极变化(p = 0.004),但筛查意愿保持一致(之前为70%,之后为72%;p = 0.650)。88名参与者报告决策冲突程度最低,大多数人报告该DA有用(平均[标准差]得分78.8[9.0]满分100分)。72%的人报告该DA有助于自我决策,但27%的人认为该DA推荐进行LCS。
本研究强调了精心设计的DA在增强对LCS的知识和态度方面的潜力,但这些改进并未转化为筛查意愿的显著变化。